作者
Hiroaki Yamaji,Kenichi Shikata,Jun Wada,Yoshiko Hayashi,Shuji Ikeda,Hirofumi Makino
摘要
Dear Sir,Membranous nephropathy is known to be associated with various underlying diseases, such as malignancies, autoimmune diseases, and viral hepatitis. The association of membranous nephropathy with psoriasis vulgaris is very rare, and only 3 cases have been reported [1, 2]. In contrast, in several patients with psoriasis vulgaris the association with IgA nephropathy has been described [3, 4, 5, 6, 7].We now report a case of membranous nephropathy associated with psoriasis vulgaris, showing the parallel deterioration of renal and skin symptoms and improvement by prednisolone therapy.A 54-year-old man was diagnosed as having psoriasis vulgaris by a dermatologist in 1985 and found to have a proteinuria in March 1993. He was referred to our clinic and hospitalized in September 1993 for further evaluation. Extensive dry erythema was recognized on his head and the left side of the abdomen. His legs were slightly edematous. The urinary protein level was 1.63 g/day, total serum protein 4.71 g/dl, serum albumin 2.61 g/dl, and creatinine clearance was 42.3 ml/min. Autoantibodies, such as rheumatoid factor, antinuclear antibody, and anti-DNA antibody, were not detected, and complements were within normal ranges. There was no evidence of hepatitis virus infection including hepatitis B and C. A percutaneous renal biopsy was performed. All glomeruli showed marked thickening of capillary walls and no proliferation of mesangial matrix and cells. By immunofluorescent microscopy, granular deposits of IgG along the capillary walls were observed. Electron microscopy showed stage IV membraneous nephropathy with subepithelial deposits and newly formed glomerular basement membranes (fig. 1). Therapy with prednisolone (40 mg/day) was first initiated (September 1993) for 2 weeks and then continued. The urinary protein level decreased to <500 mg/day, and skin lesions resolved. Prednisolone was gradually tapered and discontinued after 14 months (November 1994).In January 1996, he had a recurrence of leg edema and deterioration of skin eruption. Total serum protein was 4.29 g/dl, serum albumin 2.22 g/dl, urinary protein 2.0 g/day, and creatinine clearance 61.8 ml/min. The patient again received prednisolone therapy (40 mg/day), and both proteinuria and skin eruption resolved (fig. 2). With subsequent tapering of prednisolone maintenance therapy (10 mg/day), the patient remained free from symptoms.Psoriasis vulgaris is a chronic inflammatory disorder of the skin. The immune mechanism is considered to be involved in the pathogenesis of psoriasis vulgaris. Previous studies reported the presence of circulating immune complexes in psoriasis vulgaris [3]and activation of T cells [4]. The skin of psoriasis vulgaris patients is rich in activated CD4+ and CD8+ T cells which release proinflammatory cytokines and lymphokines which stimulate keratinocyte proliferation and induce abnormal epidermal maturation.The association of psoriasis vulgaris with autoimmune diseases such as systemic lupus erythematodes [5]and Sjögren syndrome [6]was reported. It is also known that psoriasis vulgaris can be associated with various glomerulonephritides. The precise mechanism of the association of psoriasis with membranous nephropathy still remains to be elucidated. However, the simultaneous deterioration and attenuation of renal and skin symptoms suggests that underlying common immune abnormalities may be involved in both psoriasis vulgaris and membranous nephropathy.